Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Trial of Bi-shRNAfurin and GMCSF Augmented Autologous Tumor Cell Vaccine for Advanced Cancer

NCT01061840 is registered in ClinicalTrials.gov with Gradalis, Inc. as lead sponsor.

NCT NCT01061840
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01061840 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Trial of Bi-shRNAfurin and GMCSF Augmented Autologous Tumor Cell Vaccine for Advanced Cancer
Lead sponsor
Gradalis, Inc.
Phase
Phase 1
Overall status
Completed
Start date
December 31, 2009
Completion date
January 31, 2019
Enrollment
100 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

ewings sarcoma, liver cancer, non small cell lung cancer